developing immunotherapies to fight a key culprit protein in neurodegenerative diseases.
Published 10 months ago • 103 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
45:45
dr. frank tarazi - immunotherapies for alzheimer’s disease
-
3:33
immunotherapy for mesothelioma
-
4:06
mesothelioma: how will novel immunotherapies impact surgery?
-
1:34
the need for rcts in immunotherapy for mesothelioma
-
4:46
mesothelioma causes, symptoms, diagnosis, treatment, pathology
-
4:22
seeking new treatment options for her mesothelioma
-
19:01
all about bisphosphonate therapy - zometa & aredia
-
6:49
an update on misfolded protein targets for alzheimer’s disease
-
2:33
integrating computation and experiment in functional deimmunization of therapeutic proteins
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
42:39
future immunotherapies and neuroprotective therapies
-
0:16
what are the common development challenges in therapeutic monoclonal antibodies treatment
-
13:16
adaptimmune
-
0:16
what are the common development challenges in therapeutic monoclonal antibodies treatment
-
15:21
coave therapeutics
-
16:02
missionbio
-
1:33
selecting frontline treatments strategies & monitoring patients with multiple myeloma
-
12:13
adaptimmune
-
22:26
what's your approach? treating myelofibrosis
-
1:05
improving immunotherapy outcomes in mesothelioma